Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

COVID-19

 

How cancer care is changing across Europe

Oncology patients are among the most vulnerable in the current pandemic. Will that lead to more outmigration of therapies and increased use of hypofractionation? HBI speaks to operators in the France, Germany and the UK. 

Teleradiology’s elective volumes crash

Teleradiology providers across Europe have seen volumes crash for elective reads because of the shut down of non-essential work in public hospitals, while emergency reads have been less badly affected. But operators' low fixed costs should mean that profits will hold.

Indian hospitals fear capacity crisis as lockdown lifts

Despite soaring coronavirus cases, India is lifting the lockdown it put in place at the end of March. HBI talks to one concerned operator who acknowledges that though cases are set to soar, the economic imperative is too compelling to ignore.

Anger as English dentistry set to reopen

Dental practices in England are set to reopen on Monday, June 8, but there has been widespread concern about how guidance has been released to the sector, and some anger over the timing of the reopening which, HBI hears, may be too soon.

Laboratory Diagnostics: How Covid is Reshaping the Sector

Covid has had a dramatic short-term impact on the lab sector with big falls in revenue halving as elective business fell away. But it is also an opportunity as new mass markets open up. And it may change the relationship between lab operators, consumers and government payors for good. It could also lead to a […]

Even prenatal admissions are down in Kenya

Small and medium healthcare facilities across Sub-Sarahan Africa are facing liquidation with Africa Healthcare Federation reporting an average 40% revenue drop in March. Even the maternity sector, which has held steady in Europe, has seen fewer admissions in Kenya.

Spanish dentistry re-opens but 20% contraction expected

Spain's dental clinics are re-opening with infection control protocols after being largely closed for months, but the market is expected to shrink by 20% in 2020. On top of the dealing with the COVID-19 pandemic, the largest players have been busy re-shuffling their boards and striking agreements with creditors. 

Authorities order B2C retailers to halt antibody test sales

Regulatory body Public Health England (PHE) has ordered telehealth player Babylon to stop selling B2C antibody tests until it has established their accuracy. Supplier Abbott has already said that the test is not suitable for home sample collection but players are still scrambling to sell in what's likely to be a multi-billion market.

Find Us